Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells. Issue 1 (December 2016)
- Main Title:
- Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells
- Authors:
- Reynolds, Matthew
Singh, Itender
Azad, Tej
Holmes, Brandon
Verghese, Phillip
Dietrich, Hans
Diamond, Marc
Bu, Guojun
Han, Byung
Zipfel, Gregory - Abstract:
- Abstract Background Substantial evidence suggests that amyloid-β (Aβ) species induce oxidative stress and cerebrovascular (CV) dysfunction in Alzheimer's disease (AD), potentially contributing to the progressive dementia of this disease. The upstream molecular pathways governing this process, however, are poorly understood. In this report, we examine the role of heparan sulfate proteoglycans (HSPG) in Aβ-induced vascular smooth muscle cell (VSMC) dysfunction in vitro. Results Our results demonstrate that pharmacological depletion of HSPG (by enzymatic degradation with active, but not heat-inactivated, heparinase) in primary human cerebral and transformed rat VSMC mitigates Aβ1-40 - and Aβ1-42 -induced oxidative stress. This inhibitory effect is specific for HSPG depletion and does not occur with pharmacological depletion of other glycosaminoglycan (GAG) family members. We also found that Aβ1-40 (but not Aβ1-42 ) causes a hypercontractile phenotype in transformed rat cerebral VSMC that likely results from a HSPG-mediated augmentation in intracellular Ca2+ activity, as both Aβ1-40 -induced VSMC hypercontractility and increased Ca2+ influx are inhibited by pharmacological HSPG depletion. Moreover, chelation of extracellular Ca2+ with ethylene glycol tetraacetic acid (EGTA) does not prevent the production of Aβ1-40 - or Aβ1-42 -mediated reactive oxygen species (ROS), suggesting that Aβ-induced ROS and VSMC hypercontractility occur through different molecular pathways.Abstract Background Substantial evidence suggests that amyloid-β (Aβ) species induce oxidative stress and cerebrovascular (CV) dysfunction in Alzheimer's disease (AD), potentially contributing to the progressive dementia of this disease. The upstream molecular pathways governing this process, however, are poorly understood. In this report, we examine the role of heparan sulfate proteoglycans (HSPG) in Aβ-induced vascular smooth muscle cell (VSMC) dysfunction in vitro. Results Our results demonstrate that pharmacological depletion of HSPG (by enzymatic degradation with active, but not heat-inactivated, heparinase) in primary human cerebral and transformed rat VSMC mitigates Aβ1-40 - and Aβ1-42 -induced oxidative stress. This inhibitory effect is specific for HSPG depletion and does not occur with pharmacological depletion of other glycosaminoglycan (GAG) family members. We also found that Aβ1-40 (but not Aβ1-42 ) causes a hypercontractile phenotype in transformed rat cerebral VSMC that likely results from a HSPG-mediated augmentation in intracellular Ca2+ activity, as both Aβ1-40 -induced VSMC hypercontractility and increased Ca2+ influx are inhibited by pharmacological HSPG depletion. Moreover, chelation of extracellular Ca2+ with ethylene glycol tetraacetic acid (EGTA) does not prevent the production of Aβ1-40 - or Aβ1-42 -mediated reactive oxygen species (ROS), suggesting that Aβ-induced ROS and VSMC hypercontractility occur through different molecular pathways. Conclusions Taken together, our data indicate that HSPG are critical mediators of Aβ-induced oxidative stress and Aβ1-40 -induced VSMC dysfunction. … (more)
- Is Part Of:
- Molecular neurodegeneration. Volume 11:Issue 1(2016)
- Journal:
- Molecular neurodegeneration
- Issue:
- Volume 11:Issue 1(2016)
- Issue Display:
- Volume 11, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 11
- Issue:
- 1
- Issue Sort Value:
- 2016-0011-0001-0000
- Page Start:
- 1
- Page End:
- 15
- Publication Date:
- 2016-12
- Subjects:
- Heparan sulfate proteoglycans -- Alzheimer's disease -- Vascular smooth muscle cells -- Cerebrovascular dysfunction -- Reactive oxygen species -- Oxidative stress -- Heparinase -- Heparin
Neurobiology -- Periodicals
Nervous system -- Diseases -- Periodicals
616.8 - Journal URLs:
- http://www.molecularneurodegeneration.com/ ↗
http://www.pubmedcentral.gov/tocrender.fcgi?journal=425 ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13024-016-0073-8 ↗
- Languages:
- English
- ISSNs:
- 1750-1326
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10028.xml